Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Philip Kearns"'
Autor:
Nikos Andreakis, Lone Høj, Philip Kearns, Michael R Hall, Gavin Ericson, Rose E Cobb, Benjamin R Gordon, Elizabeth Evans-Illidge
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136130 (2015)
Marine fungi are an understudied group of eukaryotic microorganisms characterized by unresolved genealogies and unstable classification. Whereas DNA barcoding via the nuclear ribosomal internal transcribed spacer (ITS) provides a robust and rapid too
Externí odkaz:
https://doaj.org/article/43dbd2f01a564f8cb383293911172153
Autor:
Nicholas Manolios, Robert J. Marano, P. Elizabeth Rakoczy, Enoch Chan, Philip Kearns, Istvan Toth, Norbert Wimmer, Michael Amon
Publikováno v:
Bioorganic & Medicinal Chemistry. 15:4091-4097
In search of new oligodeoxynucleotide (ODN) delivery agents, we evaluated novel peptides derived from core peptide H-GLRILLLKV-OH (CP). CP is a fragment designed from the T-cell antigen receptor (TCR) alpha-chain transmembrane sequence. CP was able t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad2eb1f1e3132395a09fcb41a2103e1
https://doi.org/10.1016/j.bmc.2007.03.078
https://doi.org/10.1016/j.bmc.2007.03.078
Publikováno v:
Pharmaceutical Research. 23:1473-1481
Purpose. The purpose of this study was to investigate the immunogenicity of liposomes containing mannosylated lipid core peptide (manLCP) constructs, both in vitro and in vivo, with or without the addition of the immune stimulating adjuvant Quil A. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e438b2bf4fd63dbca65835ebda27fc
https://doi.org/10.1007/s11095-006-0272-z
https://doi.org/10.1007/s11095-006-0272-z
Autor:
M. Brankov, Istvan Toth, P. Elizabeth Rakoczy, Bradley G. Thomas, Norbert Wimmer, Philip Kearns, Robert J. Marano
Publikováno v:
Experimental Eye Research. 79:525-535
Ocular neovascularisation is the leading cause of blindness in developed countries and the most potent angiogenic factor associated with neovascularisation is vascular endothelial growth factor (VEGF). We have previously described a sense oligonucleo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d9623f4a1488252e2f67959280dd30
https://doi.org/10.1016/j.exer.2004.06.023
https://doi.org/10.1016/j.exer.2004.06.023
Publikováno v:
Immunology & Cell Biology. 82:517-522
A problem facing the use of subunit peptide and protein vaccines is their inability to stimulate protective immune responses. Many different approaches have been utilized to overcome this inefficient immune activation. The approach we have taken is t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012abe367708d71a4ace980cf07372de
https://doi.org/10.1111/j.0818-9641.2004.01269.x
https://doi.org/10.1111/j.0818-9641.2004.01269.x
Publikováno v:
Letters in Peptide Science. 10:615-620
Skin penetration of the tetrapeptide Ac-Ala-Ala-Pro-Val-NH2 was assessed. This peptide sequence fits the P-P1 subsites of elastase and inhibits human neutrophil elastase competitively. Consequently this peptide may be therapeutically useful in a vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446d666bb81dfcd258b13135f791603b
https://doi.org/10.1007/bf02442595
https://doi.org/10.1007/bf02442595
Publikováno v:
The Journal of Fixed Income. 4:75-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0223089bce47b625485e40fb46755c1b
https://doi.org/10.3905/jfi.1994.408119
https://doi.org/10.3905/jfi.1994.408119
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 310(1)
Human urotensin-II (hU-II) is processed from its prohormone (ProhU-II) at putative cleavage sites for furin and serine proteases such as trypsin. Although proteolysis is required for biological activity, the endogenous "urotensin-converting enzyme" (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6094e85dc2c834ff1587e981839f5323
https://pubmed.ncbi.nlm.nih.gov/15007103
https://pubmed.ncbi.nlm.nih.gov/15007103
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics; July 2004, Vol. 310 Issue: 1 p209-14, 6p
Publikováno v:
AVJennings Limited MarketLine Company Profile. 11/27/2023, p1-17. 17p.